Evidence map›Paper›PMID 34964140›Full record

ArticleClinical cardiology2022

Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study.

Zhuxin Zhang, Chao Jiang, Liu He, Yu Bai, Jiahui Wu, Rong Hu, Qiang Lv, Man Ning, Li Feng, Ribo Tang and 6 more

Abstract read
In one paragraph

Article in Clinical cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Zhuxin ZhangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0001-6048-6610
Chao JiangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0003-1138-7960
Liu HeDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yu BaiFaculty of Science, The University of Sydney, Sydney, Australia.
Jiahui WuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Rong HuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Qiang LvDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Man NingDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li FengDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ribo TangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0003-2812-1827
Caihua SangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Deyong LongDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jianzeng DongDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xin DuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Gregory Y H LipLiverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, UK.ORCID https://orcid.org/0000-0002-7566-1626
Changsheng MaDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0002-5387-5957

Funding

Beijing Municipal Commission of Science and Technology Z1811000001618011National Key Research and Development Program of China 2018YFC1312501National Key Research and Development Program of China 2020YFC2004803National Natural Science Foundation of China 82100326
6 · The paper itself

Abstract

backgroundAnemia is a common comorbidity in patients with atrial fibrillation (AF). Reports on the association of anemia and adverse events in patients with AF, especially from Asia, are limited. METHODS AND

resultsBased on data from the Chinese Atrial Fibrillation Registry Study (CAFR), a total of 18,106 AF patients enrolled between August 2011 and December 2018 had hemoglobin (Hb) values recorded at baseline. Patients were classified into three groups according to Hb levels: 15,606 patients (86.2%) into the no anemia group (male Hb≥130 g/L; female Hb≥120 g/L), 1800 (9.9%) with mild anemia (male 110≤Hb<129 g/L; female 110≤Hb<119 g/L), and 700 (3.9%) with moderate to severe anemia (Hb≤109 g/L). Multivariable Cox regression models were used to determine if anemia was independently associated with all-cause death, cardiovascular death, or major bleeding, after adjusting for confounders. Anemia was present in 13.8% of the population at baseline. During a median follow-up of 4.01 years, the incidences of all-cause death (1.8, 4.9, and 8.9 per 100 person-years), cardiovascular death (1.0, 2.9, and 4.5 per 100 person-years), and major bleeding (0.5, 0.6, and 0.7 per 100 person-years) were gradually accentuated in patients with no anemia, mild anemia, and moderate to severe anemia, respectively. Compared with patients with no anemia, those with anemia had higher risks for all-cause death (mild anemia; adjusted hazard ratio [HR]: 1.22, 95% confidence interval [CI]: 1.08-1.38; moderate to severe anemia; adjusted HR: 1.53, 95% CI: 1.31-1.77); and cardiovascular death (mild anemia; adjusted HR: 1.29, 95% CI: 1.10-1.52; moderate to severe anemia; adjusted HR: 1.27, 95% CI: 1.03-1.57), but not for major bleeding. The association between anemia and all-cause death was similar among subgroups stratified by sex, kidney function, anticoagulant, or ablation therapy.

conclusionsAnemia was associated with increased risks of all-cause death, cardiovascular death, but no major bleeding in AF patients. The effect of anemia correction on the prognosis of patients with AF requires further study.

Indexed as

AnemiaAtrial FibrillationStrokeAnticoagulantsChinaFemaleHemorrhageHumansMaleRegistriesRisk FactorsAnticoagulantsanemiaatrial fibrillationmajor bleedingmortality

Identifiers

PMID34964140
PMCPMC8799039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.